Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($)
Total
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Deficit
Total The Joint Corp. stockholders' equity
Non-controlling interest
Balance, beginning at Dec. 31, 2019 $ 5,720,500 $ 13,899 $ 39,454,937 $ (111,041) $ (33,637,395) $ 5,720,400 $ 100
Balance, beginning (in shares) at Dec. 31, 2019   13,898,694   (15,762)      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 250,392   250,392     250,392  
Issuance of restricted stock 0 $ 16 (16)        
Issuance of vested restricted stock (in shares)   15,578          
Exercise of stock options 140,899 $ 35 140,864     140,899  
Exercise of stock options (in shares)   35,500          
Purchases of treasury stock under employee stock plans (3,774)     $ (3,774)   (3,774)  
Purchase of treasury stock under employee stock plans (in shares)       251      
Net income 814,947       814,947 814,947  
Balance, ending at Mar. 31, 2020 6,922,964 $ 13,950 39,846,177 $ (114,815) (32,822,448) 6,922,864 100
Balance, ending (in shares) at Mar. 31, 2020   13,949,772   (16,013)      
Balance, beginning at Dec. 31, 2019 5,720,500 $ 13,899 39,454,937 $ (111,041) (33,637,395) 5,720,400 100
Balance, beginning (in shares) at Dec. 31, 2019   13,898,694   (15,762)      
Stockholders' Equity [Roll Forward]              
Net income 930,532            
Balance, ending at Jun. 30, 2020 7,501,651 $ 14,043 40,309,186 $ (114,815) (32,706,863) 7,501,551 100
Balance, ending (in shares) at Jun. 30, 2020   14,042,854   (16,013)      
Balance, beginning at Mar. 31, 2020 6,922,964 $ 13,950 39,846,177 $ (114,815) (32,822,448) 6,922,864 100
Balance, beginning (in shares) at Mar. 31, 2020   13,949,772   (16,013)      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 216,081   216,081     216,081  
Issuance of restricted stock 0 $ 31 (31)        
Issuance of vested restricted stock (in shares)   30,882          
Exercise of stock options 247,021 $ 62 246,959     247,021  
Exercise of stock options (in shares)   62,200          
Net income 115,585       115,585 115,585  
Balance, ending at Jun. 30, 2020 7,501,651 $ 14,043 40,309,186 $ (114,815) (32,706,863) 7,501,551 100
Balance, ending (in shares) at Jun. 30, 2020   14,042,854   (16,013)      
Balance, beginning at Dec. 31, 2020 20,751,083 $ 14,174 41,350,001 $ (143,111) (20,470,081) 20,750,983 100
Balance, beginning (in shares) at Dec. 31, 2020   14,174,237   (17,167)      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 246,494   246,494     246,494  
Issuance of restricted stock 0 $ 8 (8)        
Issuance of vested restricted stock (in shares)   7,879          
Exercise of stock options 620,776 $ 106 620,670     620,776  
Exercise of stock options (in shares)   105,995          
Purchases of treasury stock under employee stock plans (618,154)     $ (618,154)   (618,154)  
Purchase of treasury stock under employee stock plans (in shares)       13,619      
Net income 2,314,695       2,314,695 2,314,695  
Balance, ending at Mar. 31, 2021 23,314,894 $ 14,288 42,217,157 $ (761,265) (18,155,386) 23,314,794 100
Balance, ending (in shares) at Mar. 31, 2021   14,288,111   (30,786)      
Balance, beginning at Dec. 31, 2020 20,751,083 $ 14,174 41,350,001 $ (143,111) (20,470,081) 20,750,983 100
Balance, beginning (in shares) at Dec. 31, 2020   14,174,237   (17,167)      
Stockholders' Equity [Roll Forward]              
Net income 4,998,657            
Balance, ending at Jun. 30, 2021 26,924,207 $ 14,405 43,142,391 $ (761,265) (15,471,424) 26,924,107 100
Balance, ending (in shares) at Jun. 30, 2021   14,406,148   (30,786)      
Balance, beginning at Mar. 31, 2021 23,314,894 $ 14,288 42,217,157 $ (761,265) (18,155,386) 23,314,794 100
Balance, beginning (in shares) at Mar. 31, 2021   14,288,111   (30,786)      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 283,564   283,564     283,564  
Issuance of restricted stock 0 $ 4 (4)        
Issuance of vested restricted stock (in shares)   4,218          
Exercise of stock options 641,787 $ 113 641,674     641,787  
Exercise of stock options (in shares)   113,819          
Net income 2,683,962         2,683,962  
Balance, ending at Jun. 30, 2021 $ 26,924,207 $ 14,405 $ 43,142,391 $ (761,265) $ (15,471,424) $ 26,924,107 $ 100
Balance, ending (in shares) at Jun. 30, 2021   14,406,148   (30,786)